Abstract
Abstract Gliomas are the most frequent and the most aggressive tumors of CNS. Invasiveness and existence of glioma stem-like cells resistant to conventional therapy contribute to the aggressive phenotype of the tumor. Current treatment efforts (surgery and radiation therapy) fail to prevent the relapse of secondary gliomas. Measurement of thickness of the infiltration zone surrounding the tumor mass, visualized by MRI, allows classification of patient glioma into Grade I (2-3 mm), Grade II (3-10 mm) and Grade III (>10 mm). Microarray data from classified biopsies indicate that SOX2 and HEY1 mRNAs expressions correlated with tumor invasion grade. This suggested a possible role for SOX2 and HEY1 in regulating genes involved in invasion. Lentiviruses expressing shRNAs against either SOX2 or HEY1 were used to knockdown human glioma cell lines U373 and LN319. Boyden chamber assays and wound healing assays were used as readouts for invasion and migration respectively. Gene expression analysis on glioma cells depleted for SOX2 revealed 2-5 fold down-regulation of HEY1 mRNA. Interestingly, we observed that glioma cells depleted for HEY1 showed 1-1.5 fold up-regulation for SOX2. This suggested that these transcription factors could be regulating each other. We observed that invasion and migration was strongly enhanced in SOX2 depleted cells. Consistently, our microarray data on these cells showed that mRNA of genes related to epithelial-mesenchymal-transition (EMT) were 1-3.5 fold overexpressed. In contrast, glioma cells depleted for HEY1 showed significant reduction in invasion and migration and the mRNA of genes related to EMT were 2- 5-fold downregulated. These results are consistent in supporting the hypothesis that a SOX2- HEY1 signaling loop participates in EMT and in glioma invasion. Confirmation of these observations is currently being carried out on a genetic mice model of glioma. Definition of the effectors of glioma invasion might ultimately contribute to identify targets for the development of customized therapies aimed at controlling glioma invasion. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):B168. Citation Format: Archana Ramadoss, Jean Louis Boulay, Cristobal Tostado, Marie-Francoisse Ritz, Luigi Mariani. Investigating the role of SOX2- HEY1 signaling loop in Glioma Invasion. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr B168.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
